Saturday, December 01, 2007

Reports of Sudden Vision Loss.

July 8, 2007 — The U.S. Food and Drug Presidential term (FDA) has advised healthcare professionals via news freeing of a potential difference risk of sudden sight loss that may be attributed to use of phosphodiesterase 5 (PDE-5) inhibitors.
Buy generic tadalafil - According to the news acquittance, sudden sense experience loss in one eye due to nonarteritic anterior ischemic optic neuropathy (NAION) has been reported in a size bit of patients taking viagra (Viagra, made by Pfizer, Inc.), cialis (Cialis, made by Lilly ICOS, LLC), and vardenafil HCl (Levitra, made by Bayer Pharmaceuticals Corp.) for the attention of erectile dysfunction (ED).
As of May 18, the FDA has received a unit of 43 postmarketing reports of ischemic optic neuropathy in patients using these drugs (sildenafil, n = 38; tadalafil, n = 4; vardenafil, n = 1). A absolute majority of these cases (36) appear to be of the NAION subtype; in 26 of these, the loss of esthesis has been described as continuing or permanent.
This is a part of article Reports of Sudden Vision Loss. Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

0 Comments:

Post a Comment

<< Home